Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cellsin vitro
1996
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis
1991
Classification and Grading of Gastritis
1996 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Users' Guides to the Medical Literature
1999
Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures
1999
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Treatment of skeletal disease in breast cancer with clodronate
1991
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis
2012
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Risk of Subsequent Fracture After Low-Trauma Fracture in Men and Women
2007
Vertebral morphometry in diagnosis of spinal fractures
1988
Treatment of Tumor-Induced Osteolysis by APD
1989
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Osteoporosis: now and the future
2011 Standout
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Subgroup and cost‐benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma
1994
Treatment of postmenopausal osteoporosis
2002
Effects of low doses of strontium on bone quality and quantity in rats
1990
Psoriasis
2015 Standout
Requirements for DXA for the management of osteoporosis in Europe
2004
Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon
2006
AGA technical review on osteoporosis in gastrointestinal diseases
2003
Anabolic effects of fluoride on bone
1995
Strength of Recommendation Taxonomy (SORT): A Patient-Centered Approach to Grading Evidence in the Medical Literature
2004
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
The development of binary Mg–Ca alloys for use as biodegradable materials within bone
2008 Standout
A review of postgastrectomy bone disease
1992
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trial
1995
RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSIS
1988
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Rheumatoid arthritis
2010 Standout
Understanding and controlling the bone–implant interface
1999 Standout
Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption
1992
Histomorphometric effect of six month treatment with oral risedronate in patients with multiple myeloma
1993
Bisphosphonates: The first 40years
2011
Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma
1994
The bone–titanium interfacein vitro
1990
Nutrition in Bone Health Revisited: A Story Beyond Calcium
2000
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
1990 Standout
Ghrelin: Structure and Function
2005 Standout
Bisphosphonates
1991
Bisphosphonates—much more than only drugs for bone diseases
2019
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Management of Crohn's Disease in Adults
2009 Standout
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
2009 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
Human parathyroid peptide treatment of vertebral osteoporosis
1993
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Current methods of the U.S. Preventive Services Task Force
2001 Standout
Trace Element Nutrition and Bone Metabolism
1992
Involutional Osteoporosis
1986 Standout
The role of drugs in the induction and/or exacerbation of psoriasis
2010
The control of the false discovery rate in multiple testing under dependency
2001 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
TREATMENT OF OSTEOPOROTIC FRACTURE
1984
Is there Any Interest in Combining Treatments in Osteoporosis?
2005
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Fluoride Directly Stimulates Proliferation and Alkaline Phosphatase Activity of Bone-Forming Cells
1983 Science
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Mechanisms of Bone Lesions in Multiple Myeloma
1992
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
1983 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Calcium supplementation on bone loss in postmenopausal women
2004
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
2002
Immunology of Psoriasis
2014 Standout
Incidence of hip fractures in osteoporotic women treated with sodium fluoride
1987
The skeletal intermediary organization
1983
Functional glass slides for in vitro evaluation of interactions between osteosarcoma TE85 cells and mineral-binding ligands
2004 StandoutNobel
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Treatment of established osteoporosis: a systematic review and cost-utility analysis
2002
Skeletal complications of malignancy
1997 Standout
Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
2013
Long-term fluoride therapy of postmenopausal osteoporosis
1986
Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride
1989
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Oral bisphosphonates
2000
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
A systematic review of the role of bisphosphonates in metastatic disease
2004
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of Daniel Briançon being referenced
Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis.
1983
International experience with etodolac therapy for rheumatoid arthritis: An interim report of comparative efficacy
1989
Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices
2004
Onset or exacerbation of cutaneous psoriasis during TNFα antagonist therapy
2008
Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy
1998
Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
1982
Treatment of Osteoporosis with Fluoride, Calcium, and Vitamin D
1981
[Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
1982
Journal of Bone and Mineral Research
1990
Long Term Effects of Dichloromethylene Diphosphonate in Paget's Disease of Bone
1982